{"id":35959,"date":"2026-07-03T13:33:18","date_gmt":"2026-07-03T05:33:18","guid":{"rendered":"https:\/\/aiportek.com\/?p=35959"},"modified":"2026-07-03T13:53:09","modified_gmt":"2026-07-03T05:53:09","slug":"china-biotech-cold-chain-compliance-elpro-hongke","status":"publish","type":"post","link":"https:\/\/aiportek.com\/en\/china-biotech-cold-chain-compliance-elpro-hongke\/","title":{"rendered":"[Hongke Insights] The Wave of Chinese Innovative Drugs Going Global: A Comprehensive Guide to Pharmaceutical Cold Chain Compliance and Temperature Monitoring During Transport"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"35959\" class=\"elementor elementor-35959\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-303a47ec elementor-section-stretched elementor-section-full_width elementor-section-height-min-height elementor-section-content-middle elementor-section-height-default elementor-section-items-middle\" data-id=\"303a47ec\" data-element_type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;,&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-27d5e225\" data-id=\"27d5e225\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-4e369ae3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4e369ae3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-6555484e\" data-id=\"6555484e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-397ef20e elementor-widget elementor-widget-heading\" data-id=\"397ef20e\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Hongke's latest articles<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-4b5c0d9b elementor-absolute elementor-widget elementor-widget-heading\" data-id=\"4b5c0d9b\" data-element_type=\"widget\" data-settings=\"{&quot;_position&quot;:&quot;absolute&quot;}\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">HongKe<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6d18033c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6d18033c\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1f96cecf\" data-id=\"1f96cecf\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fd50b9b elementor-widget elementor-widget-text-editor\" data-id=\"fd50b9b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d303089 elementor-widget elementor-widget-text-editor\" data-id=\"d303089\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-4b0e7b4e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4b0e7b4e\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-7a4b7cfc\" data-id=\"7a4b7cfc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-79a3214 elementor-widget elementor-widget-heading\" data-id=\"79a3214\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">[Hongke Insights] Innovative Drugs in China: Without Expanding into Overseas Markets, They Face Elimination<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-226f412 elementor-widget elementor-widget-post-info\" data-id=\"226f412\" data-element_type=\"widget\" data-widget_type=\"post-info.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-inline-items elementor-icon-list-items elementor-post-info\">\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-2358f4d elementor-inline-item\" itemprop=\"author\">\n\t\t\t\t\t\t<a href=\"https:\/\/aiportek.com\/en\/author\/hongketechnology\/\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-far-user-circle\" viewbox=\"0 0 496 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M248 104c-53 0-96 43-96 96s43 96 96 96 96-43 96-96-43-96-96-96zm0 144c-26.5 0-48-21.5-48-48s21.5-48 48-48 48 21.5 48 48-21.5 48-48 48zm0-240C111 8 0 119 0 256s111 248 248 248 248-111 248-248S385 8 248 8zm0 448c-49.7 0-95.1-18.3-130.1-48.4 14.9-23 40.4-38.6 69.6-39.5 20.8 6.4 40.6 9.6 60.5 9.6s39.7-3.1 60.5-9.6c29.2 1 54.7 16.5 69.6 39.5-35 30.1-80.4 48.4-130.1 48.4zm162.7-84.1c-24.4-31.4-62.1-51.9-105.1-51.9-10.2 0-26 9.6-57.6 9.6-31.5 0-47.4-9.6-57.6-9.6-42.9 0-80.6 20.5-105.1 51.9C61.9 339.2 48 299.2 48 256c0-110.3 89.7-200 200-200s200 89.7 200 200c0 43.2-13.9 83.2-37.3 115.9z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-author\">\n\t\t\t\t\t\t\t\t\t\tHongKeTechnology\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t<\/li>\n\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-a689c23 elementor-inline-item\" itemprop=\"datePublished\">\n\t\t\t\t\t\t<a href=\"https:\/\/aiportek.com\/en\/2026\/07\/03\/\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-calendar\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M12 192h424c6.6 0 12 5.4 12 12v260c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V204c0-6.6 5.4-12 12-12zm436-44v-36c0-26.5-21.5-48-48-48h-48V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H160V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H48C21.5 64 0 85.5 0 112v36c0 6.6 5.4 12 12 12h424c6.6 0 12-5.4 12-12z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-date\">\n\t\t\t\t\t\t\t\t\t\t<time>July 3, 2026<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t<\/li>\n\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c027dd7 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"c027dd7\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3a8309a elementor-widget elementor-widget-text-editor\" data-id=\"3a8309a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-path-to-node=\"7\">In China\u2019s innovative drug industry in 2025, there is a half-joking yet brutally honest adage: \u201cIf you don\u2019t expand into overseas markets, you\u2019ll be left behind.\u201d<\/p><p data-path-to-node=\"8\">These twelve words, which were merely a warning a few years ago, have now become the industry consensus. As price cuts in mainland China\u2019s health insurance negotiations grow increasingly steep and the consistency evaluation of generic drugs continues to squeeze the profit margins of \u201cme-too\u201d products, a large number of biotech startups have discovered that relying solely on the mainland market is simply insufficient to sustain their operations. Expanding overseas is no longer a matter of choice, but a matter of survival\u2014one that determines the very existence of these companies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9aba933 elementor-widget elementor-widget-heading\" data-id=\"9aba933\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-small\">I. From the Lab to the Global Market: China\u2019s Innovative Drugs Shift into \u201cHigh Gear\u201d<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aa4c262 elementor-widget elementor-widget-text-editor\" data-id=\"aa4c262\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-path-to-node=\"12\">In 2025, China\u2019s innovative drugs delivered impressive results in overseas markets. According to statistics from a specialized pharmaceutical database, the total value of out-licensing transactions for Chinese innovative drugs in overseas markets reached $135.655 billion in 2025, representing a year-over-year increase of approximately 161%. Even more noteworthy is that the transaction value of China\u2019s innovative drugs accounted for 49% of the global total, surpassing the United States for the first time.<\/p><p data-path-to-node=\"13\">As we enter 2026, this wave of overseas expansion shows no signs of slowing down. In the first quarter alone, the total value of outbound business development (BD) deals for innovative Chinese drugs exceeded $60 billion. This means that the transaction volume for the first three months of 2026 was already nearly half of the total for the entire year of 2024.<\/p><p data-path-to-node=\"14\">Statistics from Chinese regulatory authorities also confirm this trend. Data from the National Medical Products Administration show that in the first quarter of 2026, the total value of business development (BD) transactions for innovative drugs in China successfully surpassed $60 billion.<\/p><p data-path-to-node=\"15\">From \u201cselling products\u201d to \u201cexporting technology,\u201d and from \u201cpassive licensing\u201d to \u201cproactive strategic positioning,\u201d China\u2019s innovative drugs are shedding their former role as followers and have officially taken center stage in the global arena of innovative pharmaceuticals.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d254321 elementor-widget elementor-widget-heading\" data-id=\"d254321\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-small\">II. Turning a Loss into a Profit Through Global Product Expansion: How BeiGene Transformed Itself into a Global Biopharma Giant<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f707efe elementor-widget elementor-widget-text-editor\" data-id=\"f707efe\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-path-to-node=\"19\">If macroeconomic data provides a panoramic view, then the case of BeiGene offers a close-up. In 2025, BeiGene\u2019s annual revenue reached 382.05 billion yuan, representing year-over-year growth of more than 40%. More importantly, this marks the first time in the company\u2019s 16-year history that it has turned a full-year profit, with net income attributable to the parent company reaching 1.422 billion yuan.<\/p><p data-path-to-node=\"20\">The driving force behind these impressive results is BeiGene\u2019s in-house developed BTK inhibitor\u2014Zebutini (Baiyueze). In 2025, global sales of zebutinib reached 280.67\u4ebf\u5143\u4eba\u6c11\u5e01, representing a year-over-year increase of 48.8%. The U.S. market contributed the majority of this revenue, with a year-over-year growth rate of 45%. Currently, Zebrutinib has been approved for marketing in more than 75 markets worldwide, covering multiple indications such as chronic lymphocytic leukemia.<\/p><p data-path-to-node=\"21\">Even more striking is the proportion of overseas revenue generated by Zebrutinib. More than 90% of this product\u2019s revenue comes from overseas markets. In other words, it was precisely through expanding into overseas markets that BeiGene transformed from a biotech company reliant on external funding into a global biopharma giant with stable, self-sustaining revenue generation capabilities.<\/p><p data-path-to-node=\"22\">The story of BeiGene is, in fact, a microcosm of the broader wave of Chinese innovative drug companies expanding into the global market. As more and more biotech companies realize that globalization is the true ceiling for their growth, going global is no longer just an adventure for a handful of pioneers, but a collective endeavor for the entire industry.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-43de91f elementor-widget elementor-widget-heading\" data-id=\"43de91f\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-small\">III. The Compliance Hurdles Behind the Glitz\nThe real test begins the moment the drug leaves the factory<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f1928a3 elementor-widget elementor-widget-text-editor\" data-id=\"f1928a3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-path-to-node=\"26\">Once a consensus is reached on expanding into overseas markets, innovative pharmaceutical companies are faced with a series of very practical challenges.<\/p><p data-path-to-node=\"27\">Obtaining approval from the U.S. FDA or having an application accepted by the European EMA is merely the first step in a long journey. The real challenge begins the moment the drug leaves the factory gates\u2014how can you ensure that your drug remains within the specified temperature range and arrives intact in the hands of overseas patients after traveling thousands of kilometers and undergoing multiple transshipments and storage operations?<\/p><p data-path-to-node=\"28\">Biologics are far more temperature-sensitive than most people realize. According to the technical requirements of the FDA and the World Health Organization (WHO), most biologics must be stored and transported in a cold chain environment at temperatures between 2\u00b0C and 8\u00b0C; certain vaccines and biological samples require ultra-low-temperature conditions ranging from -20\u00b0C to -70\u00b0C; and cell and gene therapy (CGT) products must be carefully preserved throughout the entire process in liquid nitrogen at temperatures below -150\u00b0C.<\/p><p data-path-to-node=\"29\">At the same time, major global drug regulatory agencies are imposing increasingly stringent scrutiny on temperature data. The U.S. FDA\u2019s 21 CFR Part 11 explicitly stipulates that electronic temperature records used to support GMP decisions must possess the same level of data integrity and audit trail capabilities as paper records. Similarly, the EU GDP guidelines require that temperature monitoring equipment be properly maintained during transport and calibrated at least once a year. Any missing temperature records at any stage could constitute a critical deficiency during a regulatory audit.<\/p><p data-path-to-node=\"30\">For innovative pharmaceutical companies looking to expand into overseas markets, selecting a temperature monitoring solution that is recognized by global airlines, accepted by overseas regulatory agencies, and readily accepted by overseas recipients without any barriers is not only a technical guarantee of product quality but also a critical step in determining whether the product can successfully enter the target market.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-75fb422 elementor-widget elementor-widget-heading\" data-id=\"75fb422\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-small\">IV. Hongke ELPRO Temperature Monitoring Solution\nMaking Temperature Records a Globally Recognized Compliance Passport<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1c1f13b elementor-widget elementor-widget-text-editor\" data-id=\"1c1f13b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-path-to-node=\"34\">Hongke\u2019s ELPRO LIBERO C Series is the world\u2019s first brand to introduce temperature data loggers that generate reports in PDF format. These reports are fully compliant with the PDF\/A standard (ISO 19005-1), providing comprehensive support to help users meet stringent global regulatory requirements such as GMP, GLP, and FDA 21 CFR Part 11.<\/p><p data-path-to-node=\"35,0\"><b data-path-to-node=\"35,0\" data-index-in-node=\"0\">Hongke LIBERO Series Temperature Loggers<\/b><\/p><p data-path-to-node=\"36\">To address the cold chain compliance needs of Chinese pharmaceutical companies expanding into overseas markets, the LIBERO series offers the following key solutions:<\/p><ul data-path-to-node=\"37\"><li><p data-path-to-node=\"37,0,0\"><b data-path-to-node=\"37,0,0\" data-index-in-node=\"0\">Air Transport Compliance: Verifiable with Documentation:<\/b> The Hongke LIBERO series has received dual certification\u2014the \u201cCertificate of Compliance with Conditions of Carriage\u201d from the Shanghai Research Institute of Chemical Industry and the \u201cAir Transport Conditions Assessment Report\u201d from Beijing DGM\u2014and fully complies with the exceptions for functional equipment outlined in the International Air Transport Association (IATA) Dangerous Goods Regulations. Currently, more than 40 major airlines worldwide have included it on their approved lists. This means that the temperature monitoring equipment itself will not pose an obstacle during air cargo security screening, and pharmaceutical companies and freight forwarders do not need to prepare additional dangerous goods declaration documents for this purpose. <i data-path-to-node=\"37,0,0\" data-index-in-node=\"207\">(Reference Documents: Beijing DGM Dijiem Aviation Transport Hazard Identification Report \/ Shanghai Institute of Chemical Industry Transport Hazard Assessment Report)<\/i><\/p><\/li><li><p data-path-to-node=\"37,1,0\"><b data-path-to-node=\"37,1,0\" data-index-in-node=\"0\">Plug-and-play, no additional training required:<\/b> The Hongke LIBERO series is the first-of-its-kind PDF temperature logger; the PDF reports it generates can be automatically converted into tamper-proof PDF temperature data reports simply by plugging the device into any computer\u2019s USB port. Recipients anywhere in the world do not need to install specific software, purchase a card reader, or undergo operational training. For scenarios involving multiple receiving locations\u2014such as international multicenter clinical trials (MRCTs) and drug exports\u2014this \u201czero-barrier\u201d design significantly reduces the probability of human error at the operational level.<\/p><\/li><li><p data-path-to-node=\"37,2,0\"><b data-path-to-node=\"37,2,0\" data-index-in-node=\"0\">Compliant Data, Globally Recognized:<\/b> The PDF reports generated by the Hongke LIBERO series are non-editable, fully meeting the FDA\u2019s requirements for electronic records while helping users comply with major pharmaceutical supply chain regulations such as GSP, GMP, GDP, and WHO standards. From Pfizer to Novo Nordisk, and from GSK to Bayer, many of the world\u2019s top 50 pharmaceutical companies are long-standing customers of ELPRO\u2014a fact that serves as the most direct and compelling validation of its compliance capabilities.<\/p><\/li><li><p data-path-to-node=\"37,3,0\"><b data-path-to-node=\"37,3,0\" data-index-in-node=\"0\">Single-use, extremely cost-effective (great value for the price):<\/b> In export shipping scenarios, temperature loggers typically do not need to be returned, so a single-use solution is the most efficient option. Hongke\u2019s ELPRO LIBERO CB eliminates the need for return management processes and cross-border logistics costs, resulting in a significantly lower cost per use compared to solutions that require multiple returns. A single model supports multiple temperature configurations, reducing the number of SKUs in inventory and further alleviating procurement and warehousing pressures.<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aa88839 elementor-widget elementor-widget-heading\" data-id=\"aa88839\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-small\">Conclusion<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b4da2bc elementor-widget elementor-widget-text-editor\" data-id=\"b4da2bc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-path-to-node=\"40\">Returning to the opening statement: Without expanding into overseas markets, we face elimination. But entering the international market is by no means just a slogan. It means that every step\u2014from R&amp;D to production, from warehousing to distribution, and from Chinese factories to overseas patients\u2014must be re-examined and refined in accordance with global compliance standards.<\/p><p data-path-to-node=\"41\">When our innovative drugs travel thousands of kilometers to reach overseas markets, the temperature data that ensures their quality compliance must withstand scrutiny from the world\u2019s most stringent regulatory agencies. On this path to globalization, cold chain compliance is not an optional extra\u2014it is an essential prerequisite. Failure to expand into overseas markets means facing elimination; but if you\u2019re ready to enter the global market, be sure to bring along Hongke ELPRO\u2019s temperature compliance assurance.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-45ed7c8 elementor-widget elementor-widget-button\" data-id=\"45ed7c8\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/aiportek.com\/biotech\/elpro\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Go to Elpro Product Page<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t<div class=\"elementor-element elementor-element-9049411 e-flex e-con-boxed e-con e-parent\" data-id=\"9049411\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-cfcf4de e-flex e-con-boxed e-con e-parent\" data-id=\"cfcf4de\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-dbc1b58 elementor-widget elementor-widget-heading\" data-id=\"dbc1b58\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-xl\">Other Articles<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-74adc8f elementor-posts--align-left elementor-grid-3 elementor-grid-tablet-2 elementor-grid-mobile-1 elementor-posts--thumbnail-top elementor-card-shadow-yes elementor-posts__hover-gradient elementor-widget elementor-widget-posts\" data-id=\"74adc8f\" data-element_type=\"widget\" data-settings=\"{&quot;cards_row_gap&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:100,&quot;sizes&quot;:[]},&quot;cards_columns&quot;:&quot;3&quot;,&quot;cards_columns_tablet&quot;:&quot;2&quot;,&quot;cards_columns_mobile&quot;:&quot;1&quot;,&quot;cards_row_gap_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;cards_row_gap_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"posts.cards\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-posts-container elementor-posts elementor-posts--skin-cards elementor-grid\" role=\"list\">\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-35959 post type-post status-publish format-standard has-post-thumbnail hentry category-12 tag-elpro tag-45\" role=\"listitem\">\n\t\t\t<div class=\"elementor-post__card\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/aiportek.com\/en\/china-biotech-cold-chain-compliance-elpro-hongke\/\" tabindex=\"-1\" target=\"_blank\"><div class=\"elementor-post__thumbnail\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1080\" height=\"810\" src=\"https:\/\/aiportek.com\/wp-content\/uploads\/2026\/07\/640-1.webp\" class=\"attachment-full size-full wp-image-35960\" alt=\"\" srcset=\"https:\/\/aiportek.com\/wp-content\/uploads\/2026\/07\/640-1.webp 1080w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/07\/640-1-300x225.webp 300w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/07\/640-1-1024x768.webp 1024w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/07\/640-1-768x576.webp 768w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/07\/640-1-16x12.webp 16w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/07\/640-1-600x450.webp 600w\" sizes=\"(max-width: 1080px) 100vw, 1080px\" \/><\/div><\/a>\n\t\t\t\t<div class=\"elementor-post__badge\">Hongke Dry Goods<\/div>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h3 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/aiportek.com\/en\/china-biotech-cold-chain-compliance-elpro-hongke\/\" target=\"&quot;_blank&quot;\">\n\t\t\t\t[Hongke Insights] The Wave of Chinese Innovative Drugs Going Global: A Comprehensive Guide to Pharmaceutical Cold Chain Compliance and Temperature Monitoring During Transport\t\t\t<\/a>\n\t\t<\/h3>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>2026 will mark a boom period for the global expansion of China\u2019s innovative drugs and biologics. How can you ensure that cross-border shipments comply with FDA 21 CFR Part 11 and EU GDP regulations? ELPRO LIBERO temperature recorders from Hongke offer a training-free, globally recognized pharmaceutical cold chain compliance solution, helping biotech companies successfully expand into global markets such as Hong Kong and Southeast Asia.<\/p>\n\t\t<\/div>\n\t\t\n\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/aiportek.com\/en\/china-biotech-cold-chain-compliance-elpro-hongke\/\" aria-label=\"Read more about [Hongke Insights] The Wave of Chinese Innovative Drugs Going Global: A Comprehensive Guide to Pharmaceutical Cold Chain Compliance and Temperature Monitoring During Transport\" tabindex=\"-1\" target=\"_blank\">\n\t\t\tRead more\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-post__meta-data\">\n\t\t\t\t\t<span class=\"elementor-post-author\">\n\t\t\tHongKeTechnology\t\t<\/span>\n\t\t\t\t<span class=\"elementor-post-date\">\n\t\t\tJuly 3, 2026\t\t<\/span>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/article>\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-35773 post type-post status-publish format-standard has-post-thumbnail hentry category-1 category-18 tag-msr tag-52\" role=\"listitem\">\n\t\t\t<div class=\"elementor-post__card\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/aiportek.com\/en\/hongke-msr-impact-data-logger-global-top-15\/\" tabindex=\"-1\" target=\"_blank\"><div class=\"elementor-post__thumbnail\"><img decoding=\"async\" width=\"640\" height=\"440\" src=\"https:\/\/aiportek.com\/wp-content\/uploads\/2026\/06\/640-5.webp\" class=\"attachment-full size-full wp-image-35776\" alt=\"\" srcset=\"https:\/\/aiportek.com\/wp-content\/uploads\/2026\/06\/640-5.webp 640w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/06\/640-5-300x206.webp 300w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/06\/640-5-18x12.webp 18w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/06\/640-5-600x413.webp 600w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/div><\/a>\n\t\t\t\t<div class=\"elementor-post__badge\">Hongke Dynamic<\/div>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h3 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/aiportek.com\/en\/hongke-msr-impact-data-logger-global-top-15\/\" target=\"&quot;_blank&quot;\">\n\t\t\t\t[Authoritative Recognition] Hongke MSR Named One of the World\u2019s Top 15 Shock Data Logger Companies\t\t\t<\/a>\n\t\t<\/h3>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>Hongke\u2019s MSR Data Logger has been ranked among the top 15 in the global shock data logger market! Designed specifically for precision instruments, semiconductor equipment, and cold-chain logistics, it provides high-precision three-axis shock, vibration, and temperature\/humidity monitoring, comprehensively ensuring the safety of B2B cross-border logistics and supply chains. Learn more about our professional-grade transportation environment monitoring solutions today.<\/p>\n\t\t<\/div>\n\t\t\n\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/aiportek.com\/en\/hongke-msr-impact-data-logger-global-top-15\/\" aria-label=\"Read more about \u3010Authoritative Recognition\u3011Hongke MSR Named Among the Top 15 Global Manufacturers of Impact Data Loggers\" tabindex=\"-1\" target=\"_blank\">\n\t\t\tRead more\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-post__meta-data\">\n\t\t\t\t\t<span class=\"elementor-post-author\">\n\t\t\tHongKeTechnology\t\t<\/span>\n\t\t\t\t<span class=\"elementor-post-date\">\n\t\t\tJune 30, 2026\t\t<\/span>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/article>\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-35762 post type-post status-publish format-standard has-post-thumbnail hentry category-12 tag-lepide tag-36\" role=\"listitem\">\n\t\t\t<div class=\"elementor-post__card\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/aiportek.com\/en\/lepide-ai-security-monitor-permission-governance\/\" tabindex=\"-1\" target=\"_blank\"><div class=\"elementor-post__thumbnail\"><img decoding=\"async\" width=\"984\" height=\"438\" src=\"https:\/\/aiportek.com\/wp-content\/uploads\/2026\/05\/10002.webp\" class=\"attachment-full size-full wp-image-34596\" alt=\"\" srcset=\"https:\/\/aiportek.com\/wp-content\/uploads\/2026\/05\/10002.webp 984w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/05\/10002-300x134.webp 300w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/05\/10002-768x342.webp 768w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/05\/10002-18x8.webp 18w, https:\/\/aiportek.com\/wp-content\/uploads\/2026\/05\/10002-600x267.webp 600w\" sizes=\"(max-width: 984px) 100vw, 984px\" \/><\/div><\/a>\n\t\t\t\t<div class=\"elementor-post__badge\">Hongke Dry Goods<\/div>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h3 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/aiportek.com\/en\/lepide-ai-security-monitor-permission-governance\/\" target=\"&quot;_blank&quot;\">\n\t\t\t\t[Hongke Insights] Plug the Gaps Before Deploying AI: Minimize Data Breach Risks with \u201cReal-Time Monitoring + Access Control\u201d\u200b\t\t\t<\/a>\n\t\t<\/h3>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>As generative AI and AI agents are widely adopted in enterprises, behaviors such as prompt injection, over-agency, and unintentional data leaks by employees continue to amplify data leakage and compliance risks, creating an urgent need for proactive security solutions. This article leverages the Lepide Data Security Platform to build a comprehensive protection system centered on \u201cpre-deployment governance + in-operation monitoring.\u201d Through real-time sensitive data monitoring, fine-grained permission controls, end-to-end auditing, and automated incident response capabilities, it can integrate with SIEM and SOAR systems to form a closed-loop risk management system. The platform automatically consolidates excessive permissions, and abnormal behavior triggers rapid response measures such as account freezing and system isolation. This addresses the challenges of excessive AI permissions and confidential data leaks while meeting compliance requirements under regulations such as GDPR, thereby establishing a robust data security defense for enterprises implementing AI.<\/p>\n\t\t<\/div>\n\t\t\n\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/aiportek.com\/en\/lepide-ai-security-monitor-permission-governance\/\" aria-label=\"Read more about \u3010Hongke Insights\u3011Plugging Gaps Before AI Deployment: Mitigating Data Breach Risks with \u201cReal-Time Monitoring + Access Control\u201d\u200b\" tabindex=\"-1\" target=\"_blank\">\n\t\t\tRead more\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-post__meta-data\">\n\t\t\t\t\t<span class=\"elementor-post-author\">\n\t\t\tHongKeTechnology\t\t<\/span>\n\t\t\t\t<span class=\"elementor-post-date\">\n\t\t\tJune 26, 2026\t\t<\/span>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/article>\n\t\t\t\t<\/div>\n\t\t\n\t\t\t\t<div class=\"e-load-more-anchor\" data-page=\"1\" data-max-page=\"38\" data-next-page=\"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959\/page\/2\/\"><\/div>\n\t\t\t\t<nav class=\"elementor-pagination\" aria-label=\"Pagination\">\n\t\t\t<span class=\"page-numbers prev\">\"<\/span>\n<span aria-current=\"page\" class=\"page-numbers current\"><span class=\"elementor-screen-only\">Page<\/span>1<\/span>\n<a class=\"page-numbers\" href=\"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959\/page\/2\/\"><span class=\"elementor-screen-only\">Page<\/span>2<\/a>\n<a class=\"page-numbers\" href=\"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959\/page\/3\/\"><span class=\"elementor-screen-only\">Page<\/span>3<\/a>\n<span class=\"page-numbers dots\">...<\/span>\n<a class=\"page-numbers\" href=\"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959\/page\/5\/\"><span class=\"elementor-screen-only\">Page<\/span>5<\/a>\n<a class=\"page-numbers next\" href=\"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959\/page\/2\/\">\"<\/a>\t\t<\/nav>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>2026 will mark a boom period for the global expansion of China\u2019s innovative drugs and biologics. How can you ensure that cross-border shipments comply with FDA 21 CFR Part 11 and EU GDP regulations? ELPRO LIBERO temperature recorders from Hongke offer a training-free, globally recognized pharmaceutical cold chain compliance solution, helping biotech companies successfully expand into global markets such as Hong Kong and Southeast Asia.<\/p>","protected":false},"author":1,"featured_media":35960,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[12],"tags":[47,45],"class_list":["post-35959","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-12","tag-elpro","tag-45"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/comments?post=35959"}],"version-history":[{"count":4,"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959\/revisions"}],"predecessor-version":[{"id":35967,"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/posts\/35959\/revisions\/35967"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/media\/35960"}],"wp:attachment":[{"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/media?parent=35959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/categories?post=35959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aiportek.com\/en\/wp-json\/wp\/v2\/tags?post=35959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}